Serial interferon-γ release assay in children with latent tuberculosis infection and children with tuberculosis

Pediatric Pulmonology

Volumn 47, Issue 4, 2012, Pages 401-408

  Nenadić, Nataša ^a   Kirin, Branka Kristić ^a   Letoja, Ivka Zoričić ^a   Plavec, Davor ^a   Topić, Renata Zrinski ^a   Dodig, Slavica ^a  

^a SREBRNJAK CHILDREN S HOSPITAL   (Croatia)

Author keywords

children; interferon release assay; latent tuberculosis infection; tuberculin skin test; tuberculosis

Indexed keywords

BCG VACCINE; GAMMA INTERFERON;

ACID FAST BACTERIUM; ADULT; ARTICLE; BACTERIUM CULTURE; CHILD; CHILD CARE; CYTOLOGY; FEMALE; FOLLOW UP; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT MONITORING; PRIORITY JOURNAL; PROPHYLAXIS; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST; TUBERCULOSIS; VACCINATION;

ADOLESCENT; ANTITUBERCULAR AGENTS; BCG VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; TUBERCULOSIS, PULMONARY;

EID: 84859108159     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21555     Document Type: Article

References (34)

1. World Health Organisation. Guidance for national tuberculosis programmes on the management of tuberculosis in children. Int J Tuberc Lung Dis 2006; 10: 1091-1097.
2. Lewinsohn D, Gennaro M, Scholvinck D,. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis 2004; 8: 658-674. (Pubitemid 38625078)
3. Mardešić D,. Tuberculosis. In:, Mardešić D, editor. Paediatrics, 6th edition. Zagreb: Okolska knjiga; 2000. pp. 477-494.
4. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H,. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube Test. Pediatrics 2009; 123: 30-37.
5. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F,. Influence of bacille Calmette-Guérin vaccination on size of tuberculin skin test reaction: to what size ? Clin Infect Dis 2005; 40: 211-217. (Pubitemid 40110663)
6. Kang YA, Lee HW, Yoon HI, Cho BL, Han SK, Shim YS, Yim JJ,. Discrepancy between the tuberculin skin test and the whole blood interferon-γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-2761.
7. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 1161: 376-395.
8. Pai M, Zwerling A, Menzies D,. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008; 149: 177-184.
9. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D,. Interferon-gamma release assay and childhood tuberculosis: systemetic review and meta-analysis. Int J Tuberc Lung Dis 2011; 15: 1018-1032.
10. Bamford AR, Crook AM, Clark JE, Nademi Z, Dixon G, Paton JY, Riddell A, Drobniewski F, Riordan A, Anderson ST, Williams A, Walters S, Kampmann B,. Comparison of interferon-gamma release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child 2010; 95: 180-186.
11. Pai M, O'Brien R,. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions ? PLoS Med 2007; 4: e208.
12. Kampmann B, Whittaker E, Williams A, Walters S, Gordon A, Martinez-Alier N, Williams B, Crook AM, Hutton A-M, Anderson ST,. Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009; 33: 1374-1382.
13. Mazurek M, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K,. Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection-United States, 2010. IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep 2010; 59: 1-25.
14. Lewinsohn DA, Lobato MN, Jereb JA,. Interferon-gamma release assays: new diagnostic tests for Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr 2010; 22: 71-76.
15. Dyrhol-Riise AM, Gran G, Wentzel-Larsen T, Blomberg B, Haanshuus CG, Mørkve O,. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country. BMC Infect Dis 2010; 10: 57. DOI: 10.1186/1471-2334-10-57.
16. Behr A, Hopewell PC, Paz EA, Kawamura LM, Schecter GF, Small PM,. Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis. Am J Respir Crit Care Med 1998; 158: 465-469. (Pubitemid 28378174)
17. QuantiFERON-TB Gold In Tube test, Package insert. 2011. Available from:.
18. Centers for Disease Control and Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54: 1-141.
19. Marusteri M, Bacarea V,. Comparing groups for statistical differences: how to choose the right statistical test ? Biochem Med 2010; 20: 15-32.
20. Menzies D, Pai M, Comstock G,. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354. (Pubitemid 351650594)
21. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis Infection-United States, 2010. MMWR 2010; 59: 1-26.
22. Ravn P, Munk ME, Andersen AB,. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 2005; 12: 491-496. (Pubitemid 41175315)
23. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H,. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children. A systematic review and meta-analysis. Pediatr Infect Dis J 2011; 30: 1-7.
24. European Centre for Disease Prevention and Control. Mastering the basics of TB control: Development of a handbook on TB diagnostic methods. Stockholm: ECDC; 2011. 1-101 Stockholm: ECDC; May 2011. DOI: 10.2900/39099.
25. Menzies D,. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999; 159: 15-21. (Pubitemid 29036497)
26. Hermann JL, Belloy M, Porcher R, Simonney N, Aboutaam R,. Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PloS ONE 2009; 4: e4130.
27. Nicol MP, Pienaar D, Wood K, Eley B, Wilkinson RJ, Hendersen H, Smith L, Samodien S, Beatty D,. Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis 2005; 40: 1301-1308. (Pubitemid 40570240)
28. Ewer K, Millington KA, Deeks JJ, Alvarez L, Bryant G, Lalvani A,. Dynamic antigen-specific T-cell responses after point-sorce exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 2006; 174: 831-839. (Pubitemid 44511666)
29. Connel TG, Davies M-A, Johannisen C, Wood C, Pienaar S, Wilkinson KA, Wilkinson RJ, Zar HJ, Beatty D, Nicol MP, Curtis N, Eley B,. Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculosis treatment in HIV-infected children. BMC Infect Dis 2010; 10: 138. accessed on May 26, 2011.
30. Takayanagi K, Aoki M, Aman K, Mitarai S, Harada N, Higuchi K, Okumura M, Yoshiyama T, Ogata H, Moru T,. Analysis of an interferon-gamma release assay for monitoring the efficacy of anti-tuberculosis chemotherapy. Jpn J Infect Dis 2011; 64: 133-138.
31. Pai M, Joshi R, Dogra S, Zwerling AA, Gajalakshmi D, Goswami K, Reddy MVR, Kalantri S, Hill PC, Menzies D, Hopewell PC,. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009; 13: 84-92.
32. Ringshausen FC, Nienhaus A, Schablon A, Schlösser S, Schultze-Werninghaus G, Rohde G,. Predictors of persistently positive Mycobacterium tuberculosis-specific interferon-gamma responses in the serial testing of health care workers. BMC Infect Dis 2010; 10: 220. Accessed on May 25, 2011.
33. Veerapathran A, Joshi R, Goswami K, Dogra S, Moodie EEM, Reddy MVR, Kalantri S, Schwartzman K, Behr MA, Menzies D, Pai M,. T-cell assays for tuberculosis infection: Deriving cut-offs for conversions using reproducibility data. PLoS ONE 2008; 3: e850. DOI: 10.1371/journal.pone.0001850. (Pubitemid 351936464)
34. Pai M,. Spectrum of latent tuberculosis-existing tests cannot resolve the underlying phenotypes. Nat Rev Microbiol 2010; 8: 242-243. DOI: 10.1038/nrmicro2236-c1. Available from: http://dx.doi.org/10.1038/nrmicro2236- c1.